Eikon Therapeutics, Inc. (NASDAQ:EIKN) Stock Now Rated “Moderate Buy” by Wall Street Analysts
Eikon Therapeutics, Inc. (NASDAQ:EIKN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation, four have given a buy recommendation and one […]
13 Oct 12:17 · The Markets Daily